HAMBURG, Germany — A combination of the antiviral drugs pleconaril and ribavirin slowed the decline of pancreatic insulin production compared with placebo in children and adolescents with newly ...

SIOUX FALLS, S.D. (KELO) — The FDA approved a new drug called Teplizumab that can delay the onset of Type 1 Diabetes, especially in children. Sanford researchers dedicated to finding a cure say this ...

Doctors hailed the FDA approval as a "watershed moment." For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of Type 1 diabetes.

Researchers identify genetic markers that predict the rate of β-cell failure in type 1 diabetes, facilitating earlier, personalized care strategies Type 1 diabetes (T1D) is an autoimmune condition ...

Please provide your email address to receive an email when new articles are posted on . A supplement of Vitamin D2 may improve insulin sensitivity and slow the increase of HbA1c for children and ...

A prospective cohort study found that diabetes and insulin resistance were the strongest risk factors for premature onset of coronary heart disease (CHD) among American women. Results were published ...

This week, the FDA approved a new treatment called teplizumab that delays the onset of type 1 diabetes. TZIELD, the brand name, will total $193,000 over the 14-day treatment. Experts say the new ...

Clustering youth-onset T2D reveals distinct groups but offers no better clinical utility than simple measures for predicting complications.

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

MODY is a form of monogenic diabetes that may not present any symptoms or could appear like type 1 or type 2 diabetes. This can also lead to misdiagnosis and treatments that don’t work effectively.